Multiple myeloma (MM) remains incurable. Despite advances in treatment and aggressive first-line therapy, most patients relapse. The pursuit for tolerable and effective treatments for heavily treated patients in the relapsed/refractory (R/R) setting has resulted in novel targets and therapies, including four bispecific antibodies (BsAbs). Because these agents have unique adverse event profiles which can be life-threatening, patients are typically hospitalized during step-up dosing to ensure proper pretreatment, monitoring, and supportive care. Many institutions are piloting outpatient administration of BsAbs to increase access to, reduce inpatient hospitalizations, lower overall healthcare costs, and enhance patients experiences. Yet administration of BsAbs in community settings is challenged by lack of experience coupled with requirements for multidisciplinary care and poorly aligned infrastructures. This activity supports community providers in assessing their infrastructure, protocols, and workforce to implement the clinical and operational elements necessary for safe and effective outpatient BsAb administration. This activity also engages academic providers to support improved care coordination and transitions as well as mentoring of community specialists.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
83% of listed courses are free
45 of 54 courses listed here are free.
Collected from the provider’s public pages · source
Top 6 courses
-
-
-
ECHO-Chicago: Pediatric ADHD & Autism
15 Credits
-
-
-
Specialties served/covered
- Addiction Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Clinical Cardiac Electrophysiology
- Communication & Shared Decision-Making
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Hematology
- Hospice & Palliative Medicine
- Infectious Disease
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Oncology
- Neonatal-Perinatal Medicine
- Nephrology
- Neurology
- Neuroradiology
- Neurosurgery
- Pain Medicine
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Practice Management & Ethics
- Rheumatology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
Faculty 2
All facultyPricing
Free
Reported to ACCME by the provider
- Online course / module
- Credit · Up to 4.5 credits
- Commercial Support
-
ReleasedApr 10, 2026
-
Last day to claim creditApr 11, 2027 6 months left
-
Collaborative Institutional Training Initiative (CITI Program) +1 IRB Administration Course 2026
-
PRIME Education, Inc. (PRIME®) Accelerating Evidence Into Practice: Optimizing Bispecific Antibody Administration for R/R DLBCL and FL
-
Plexus Communications +1 CELMoDs for Multiple Myeloma in the Veterans Administration: Optimizing RRMM Treatment With Potent Immunomodulatory Drugs
-
University of Chicago School of Medicine Building Clinical Capacity for Optimal Asparaginase-Based Treatment in Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Approaches in Pediatric, Adult, and Adolescent and Young Adult Patients
-
University of Chicago School of Medicine Strategies for Improving ERBB2 (HER2) Testing in NSCLC Within Community Settings
-
University of Chicago School of Medicine Out-of-the-Box Solutions for Building Clinical Capacity in Community Settings to Improve Standardized ERBB2 (HER2) Testing in NSCLC
